Results 111 to 120 of about 1,454,033 (283)

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Study on phosphorous-doped cobalt-nitrogen-carbon catalysts for electrocatalytic reduction of carbon dioxide

open access: yes能源环境保护
The burning of fossil fuels has led to a rapid increase in the concentration of carbon dioxide (CO_2) in the atmosphere, resulting in a serious energy and environmental crisis. Electrocatalytic reduction of CO_2 to value-added chemicals and fuels, driven
LI Bingyi   +5 more
doaj   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Carbon Dioxide Emissions in Germany: Stagnating in 2004 [PDF]

open access: yes
CO2 emissions from energy consumption in Germany fell by nearly 1% in 2004 from the previous year to a good 834 million tonnes. However, taking into account temperature effects and the reduction in stocks of light heating oil in 2004, which was ...
Hans-Joachim Ziesing
core  

Electrochemical CO2 reduction

open access: yes, 2015
The atmospheric concentration of CO2 has increased significantly during the last two centuries. Since CO2 is considered to be one of the largest contributors to the greenhouse effect and is postulated to cause global warming, it is important to stabilize and/or reduce its concentration. Apart from regulations for the amount of CO2 that may be emmitted,
openaire   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Organic Chemistry and the Potentials of the Bulk-Reduction of CO2

open access: yesCHIMIA, 1988
André M. Braun, David G. Skolnick
doaj   +1 more source

CO2 Reduction Characteristics at Pt0.5Ru0.5/C Cathode of H2-CO2 Polymer Electrolyte Fuel Cell

open access: yesElectrochemistry
CH4 production by CO2 reduction using a membrane electrode assembly containing a Pt/C electrocatalyst was recently demonstrated. Because this CO2 reduction reaction occurs at approximately its theoretical electrode potential, it is possible to generate ...
Shofu MATSUDA   +2 more
doaj   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy